🇺🇸 FDA
Pipeline program

Inactivated types 1, 2, and 3 poliovirus, D antigens

IPV26

Phase 2 mab completed

Quick answer

Inactivated types 1, 2, and 3 poliovirus, D antigens for Poliomyelitis is a Phase 2 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Poliomyelitis
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials